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We compared the herpes simplex virus type 1 (HSV)-specific memory B cell (MBC) populations generated by footpad and intranasal infection
in mice. Both routes of infection generated transient antibody-secreting cell responses in the draining lymph nodes and spleen, and sustained
circulating IgG. HSV-specific IgG MBCs, analyzed by limiting dilution assay approximately 8 weeks after infection, were distributed in a range of
lymph nodes and in the spleen and Peyer's patches. Overall, the route of infection had little effect on the MBC frequency in each anatomical
location. Interestingly, after both routes of infection there was a trend towards preferential MBC accumulation in the mediastinal lymph node.
Intravaginal challenge of mice primed by footpad or intranasal infection generated similar secondary IgG responses. Our findings indicate that the
widespread dispersion of MBCs to lymphoid tissues throughout the body is largely independent of the route of infection, but may be influenced by
tissue-specific factors.
© 2006 Elsevier Inc. All rights reserved.Keywords: Herpes simplex virus; Memory B cell; Antibody response; Genital tractIntroduction
The B cell response to infection and vaccination generates
long-lived plasma cells (LLPCs) and memory B cells (MBCs),
the two cellular components of B cell memory (McHeyzer-
Williams and McHeyzer-Williams, 2005). LLPCs are typically
recognized as bone marrow (BM)-resident cells that are
primarily responsible for maintaining high circulating antibody
(Ab) levels (Hyland et al., 1994; Sangster et al., 1995; Slifka et
al., 1995, 1998). Plasma cells may also traffic to mucosal sites
and establish long-lasting populations that produce locally
protective Ab (Jones and Ada, 1987; Liang et al., 2001). MBCs
are also long-lived (Schittek and Rajewsky, 1990) but, unlike
plasma cells, they are quiescent, non-Ab-secreting cells that
circulate and distribute to organized lymphoid tissues through-
out the body (Bachmann et al., 1994; Blink et al., 2005; Crotty⁎ Corresponding author. Fax: +1 865 974 4007.
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divide and differentiate into plasma cells and mediate the rapid,
vigorous, and high-affinity secondary Ab response. In this way,
the MBC response supplements pre-existing Ab and contributes
substantially to Ab-mediated protection. Non-specific activa-
tion of MBCs by a variety of signals may also contribute to the
maintenance of long-lasting plasma cell populations (Bernas-
coni et al., 2002).
Quantitative aspects of MBC populations generated by viral
infection and vaccination have received little attention. This is
important information, since the number and location of MBCs
may be significant determinants of protective immunity.
Notably, Slifka and Ahmed (1996) applied a limiting dilution
assay (LDA) to determine virus-specific MBC frequencies after
lymphocytic choriomeningitis virus (LCMV) infection in a
mouse model. LCMV-specific MBCs circulated in the blood and
established frequencies of approximately 1 in 104 lymphocytes
in lymph nodes and spleen (Slifka et al., 1998). However, similar
analyses of other viral systems have not been undertaken. The
extent of MBC dispersion is not well established, and the effect
of virus type and route of infection has not been investigated.
Fig. 1. The HSV-specific ASC response to footpad infection. The kinetics of
virus-specific ASC responses in the PLN (A), spleen (B), and bone marrow
(C) were determined for B6 mice infected in the footpad with HSV. Cell
suspensions were prepared from individual mice and the ELISPOT assay was
used to enumerate HSV-specific ASCs. Results are expressed as the number of
ASC/1×105 or 5×105 nucleated cells. The mean±SE is shown for 3 mice.
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human pathogen that typically replicates in epithelial cells
prior to establishing latency in sensory neurons (Khanna
et al., 2004). The virus can produce both cutaneous and
mucosal infections, since the epithelial cells targeted include
epidermal cells of the skin and cells of mucosal surfaces.
These different forms of infection can be modeled in the
mouse by administering the virus via different routes
(Biswas and Rouse, 2005; Pereira et al., 2001; Reading
et al., 2006; Simmons et al., 1997). We have recently
developed an LDA for the determination of HSV-specific
MBC frequencies (Li et al., 2006). In the current study, we
apply this assay in a quantitative analysis of the HSV-
specific MBC pools generated in the mouse model by
footpad infection or by infection of the respiratory tract. Our
findings indicate that the dispersion and response of HSV-
specific MBCs is largely unaffected by the route of
immunization. Nevertheless, lymphoid tissue preferences in
MBC localization were identified.
Results
HSV-specific antibody response to cutaneous and mucosal
infection
Initial experiments determined the kinetics of HSV-specific
Ab production following two forms of infection: cutaneous
infection (footpad inoculation) and infection of the respiratory
tract [intranasal (i.n.) inoculation]. The ELISPOT assay was
used to enumerate HSV-specific Ab-secreting cells (ASCs) in
different tissues. Footpad infection generated responses in the
draining popliteal lymph node (PLN) and the spleen character-
ized by an early peak of IgM ASCs, followed by increased
numbers of cells producing IgG isotypes, with IgG2b and IgG2c
predominating (Figs. 1A and B). By day 30, responses in the
PLN and spleen had substantially waned. However, at this time
point a population of IgG ASCs was established in the BM (Fig.
1C). IgA ASCs were essentially absent from the PLN response,
and present at only very low frequencies in the spleen and later
in the bone marrow. The pattern of responses to i.n. infection
resembled that following footpad infection, but was delayed by
2–4 days in the draining lymph nodes and spleen (Fig. 2).
Notably, i.n. infection generated an IgA response. This was
most apparent when nasal-associated lymphoid tissue (NALT),
a well-established IgA inductive site (Liang et al., 2001), and
cervical lymph nodes (CLN) were sampled on day 8 (Fig. 2E),
indicating that transient IgA induction occurs early in the
response.
Virus-specific IgG in serum plateaued at similar levels
after footpad and i.n. infection (Fig. 3A). However, the initial
increase was more rapid after footpad infection, correlating
with the kinetics of the ASC response. The low levels of
virus-specific IgA in serum also correlated with IgA ASC
formation. Only i.n. infection resulted in virus-specific IgA
in vaginal secretions (Fig. 3B), emphasizing the importance
of mucosal antigen administration in the induction of IgA
responses.HSV-specific MBCs generated by cutaneous and mucosal
infection
A newly developed LDA (Li et al., 2006) was used to
determine HSV-specific IgG MBC frequencies in a range of
lymphoid tissues 45–65 days after footpad and i.n. infection.
At this time, the ASC response had waned and a stable
distribution of MBCs would be expected (Bachmann et al.,
1994; Slifka et al., 1998). Following both routes of infection,
HSV-specific MBCs were detected in all lymphoid tissues
examined (Fig. 4), consistent with the concept of a wide-
spread dispersion of these cells. MBC frequencies in the
PLN were generally higher following footpad compared
with i.n. infection, perhaps reflecting the central role of the
PLN in responding to Ag deposited in the footpad.
Otherwise, however, the route of infection had little effect
on the MBC frequencies established in each anatomical
location, suggesting an additional influence of local tissue
factors on MBC distribution patterns. An interesting trend
after both routes of infection was the preferential localiza-
tion of HSV-specific MBCs in the mediastinal lymph node
(MLN). The presence of MBCs in Peyer's patches (PP)
after footpad infection demonstrates that mucosal infection
is not a prerequisite for IgG MBC migration to mucosa-
associated lymphoid tissues.
Fig. 2. The HSV-specific ASC response to i.n. infection. The kinetics of virus-
specific ASC responses in the CLN (A), MLN (B), spleen (C), and bone marrow
(D) were determined for B6 mice infected i.n. with HSV. ASC responses in the
CLN and NALT were compared on day 8 after infection (E). Cell suspensions
were prepared from individual mice or from a pool of 3 mice for NALT, and the
ELISPOT assay was used to enumerate HSV-specific ASCs. Results are
expressed as the number of ASC/1×105 or 5×105 nucleated cells. The NALT
response is representative of two separate experiments; otherwise, the mean±SE
is shown for 3 mice.
Fig. 3. HSV-specific Ab levels. B6 mice were infected with HSV given into the
footpad (fp) or i.n. Serum levels of virus-specific IgG and IgAwere determined
at intervals after infection (A), and vaginal wash IgG and IgA levels were
determined on day 23 (B). Titers were measured by ELISA and are expressed in
arbitrary units per milliliter. Each point represents the mean±SE for 3 mice.
Baseline IgG levels in uninfected mice were 30±20 and <1 in serum and vaginal
wash, respectively; IgA levels were <1 in both serum and vaginal wash.
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To extend our analysis of the MBC pools generated by
footpad and i.n. HSV infection, we used intravaginal HSV
challenge to evaluate MBC activation in vivo. Mice were held
for 50 days after footpad or i.n. HSV infection, and then
challenged intravaginally with the virulent McKrae strain of
HSV. The ASC response was determined 5 days after challenge
in the iliac lymph nodes (IliLN), the primary lymph nodes
draining the vaginal tract (King et al., 1998). Naïve mice
infected intravaginally had few HSV-specific ASCs in the IliLN
on day 5, indicating that the response in the immune micereflected MBC activation (Fig. 5B). The HSV-specific IgG
recall response was not significantly different after footpad or
i.n. priming. This result is consistent with the similar IgG MBC
frequencies in the IliLN following both routes of priming. The
IgG1 component of the recall response was significantly
stronger after footpad compared with i.n. priming, raising the
possibility of differences in the isotype expression profile of
responding IgG MBCs. Interestingly, i.n. priming did not
enhance the IgA component in the recall response to
intravaginal challenge. Overall, the switched isotype profiles
of the primary and recall responses in the IliLN to intravaginal
infection remained largely similar (Figs. 5A and B), suggesting
a strong element of local regulation of the quality of MBC
responses.
Discussion
The current study was undertaken to add to the very limited
quantitative information available on the dispersed MBC
populations generated by viral infections. We used a mouse
model of HSV infection to compare the MBC pools generated
by primary infection of the skin (footpad inoculation) and the
respiratory tract (i.n. inoculation). The virus replicates well in
both of these locations and is cleared with approximately the
same kinetics (Jones et al., 2000; Reading et al., 2006). Our
analysis demonstrated that the primary infections elicited robust
HSV-specific B cell responses in the draining lymph nodes and
spleen, and resulted in similar virus-specific bone marrow
plasma cell numbers and circulating IgG titers (Figs 1, 2,
and 3A). Ag deposition at mucosal surfaces favors IgA
formation, and it was therefore not surprising that the early
response to i.n. infection included a small IgA component that
was absent from the response to footpad infection. Although
small, this IgA response was associated with the appearance of
HSV-specific IgA in serum and vaginal secretions (Fig. 3).
Surprisingly, IgA induction in the respiratory tract was most
apparent in the NALT, but was essentially absent from the CLN
and MLN, the major sites of IgA production following infection
Fig. 5. Primary and secondary HSV-specific ASC response to intravaginal
infection. The HSV-specific ASC response to intravaginal infection is shown for
naïve mice (A), and as a comparison of naïve and immune mice sampled on
day 5 after infection (B). Immune mice were generated by footpad (fp) or i.n.
HSV infection, and held for 50 days before intravaginal challenge. Mice were
infected intravaginally with the McKrae strain of HSV after Depo-provera
synchronization. Responses in the draining IliLN were determined by ELISPOT
assay. Results are expressed as the number of ASC/1×105 nucleated cells. The
mean±SE is shown for 6 mice. ∗IgG1 response compared after fp and i.n.
priming, P<0.02. Other isotype responses and the IgG response as a whole
(sum of IgG1, IgG2b, IgG2c, and IgG3) were not significantly different after fp
and i.n. priming.
Fig. 4. Distribution of HSV-specific MBCs. HSV-specific IgGMBC frequencies
in different lymphoid tissues are shown after footpad (A) and i.n. (B) HSV
infection. B6 mice were sampled 45–60 days after infection, and single-cell
suspensions were prepared from a range of lymph nodes (CLN, MLN, IngLN,
IliLN, and PLN), and from the spleen and PP. Lymph node and PP cells were
pooled from two or more mice; individual spleens were analyzed. MBC
frequencies were determined by LDA using inactivated HSV for in vitro MBC
stimulation. Frequencies are expressed per 105 B220+ cells to accommodate
differences in the proportion of B cells in different lymphoid tissues. Results
represent the mean±SE of 4–5 determinations. a: MLN compared with PP after
footpad infection, P<0.05. b: PLN compared with PP after footpad infection,
P<0.05; PLN after footpad infection compared with PLN after i.n. infection,
P<0.05. c: CLN compared with IngLN and PLN after i.n. infection, P<0.05. d:
MLN compared with IngLN, PLN, spleen, and PP after i.n. infection, P<0.05.
e: Spleen compared with IngLN and PLN after i.n. infection, P<0.05.
Otherwise, MBC frequencies in different anatomical sites were not significantly
different within the footpad-infected group, or within the i.n.-infected group.
With the exception of the PLN, MBC frequencies were not significantly
different when the same anatomical site was compared after footpad and i.n.
infection.
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1997, 2003). HSV resembles murine gammaherpesvirus 68 in
the induction of minimal IgA responses in the CLN and MLN
following respiratory tract infection (Sangster et al., 2000),
raising the possibility that herpesviruses in general may
selectively down-regulate IgA responses in some locations.
Interestingly, HSV-specific IgA ASCs were present in the BM
of footpad-infected mice on day 30, and these cells were
presumably responsible for the virus-specific serum IgA that
was detected only later in the response. Stochastic factors may
play a role in the isotype expression profile of the bone marrow
plasma cell population, which does not necessarily reflect that
directed by local factors in responding lymph nodes (Hyland
et al., 1994).
Previous studies indicate that MBCs migrate via the blood
from their sites of formation and, by approximately 3 weeks
after immunization, have established frequencies in distant
lymphoid tissues that remain stable for many months (Bach-
mann et al., 1994; Blink et al., 2005; Slifka et al., 1998). Thus,
our analysis of HSV-specific MBC populations generated by
footpad and i.n. infection was performed when full dispersionand stable frequencies of these cells would be expected (Fig. 4).
Our findings are consistent with the concept of widespread
dispersion of IgG MBCs, and indicate that the extent of
dispersion is independent of the form of Ag exposure.
Interestingly, IgG MBCs generated by footpad infection
migrated to the mucosa-associated PP, suggesting that non-
mucosal vaccination strategies generate MBCs that are well
placed to respond to mucosal challenges. Our findings also
indicate that the dispersion of MBCs to lymphoid tissues is not
equal, and may be influenced by local tissue factors. One factor
may be whether the lymphoid tissue participated in the response
to infection. For a period of time after infection, MBC
frequencies are highest at sites of formation in responding
lymphoid tissues. This situation gradually changes as responses
wane and MBCs disperse, but the rate of change is likely to be
dependent on the experimental system (Bachmann et al., 1994;
Baine and Thorbecke, 1982). Thus, in our studies, the site of Ag
deposition may have contributed to the trend towards higher
140 D.J. Vanitha et al. / Virology 360 (2007) 136–142MBC frequencies in the PLN and MLN following footpad and
i.n. infection, respectively. Our studies also suggest that other
tissue-specific factors may play a role. In particular, this
possibility is raised by the trend towards higher MBC
frequencies in the MLN compared with some other sites after
footpad infection, even though the MLN does not drain the
footpad. MBC trafficking patterns and the molecules that
regulate this movement are not well defined, and may differ for
different MBC subsets (Roy et al., 2002). Since MBCs home to
all lymph nodes, even in the absence of ongoing inflammation,
one trafficking pattern is likely to be the same as that used by
naïve B cells and involve the L-selectin-mediated movement of
cells from blood to lymph nodes across high endothelial venules
(Kim, 2004). The trend towards higher MBC frequencies in the
MLN, regardless of the route of infection, may reflect a
tendency for MBCs to also leave the circulation in the lung and
enter the MLN via draining lymphatics. This trafficking
pathway has been established for CD8+ memory T cells
(Zammit et al., 2006).
To further evaluate the distribution of MBCs generated by
different routes of HSV infection, immune mice were
challenged intravaginally and the secondary B cell response
determined in the draining IliLN (Fig. 5). This strategy was used
because the route of Ag administration that induces optimal
protection against genital HSV infection has been a focus of
recent investigations. A vigorous secondary B cell response is
likely to contribute significantly to vaginal protection (Morrison
et al., 2001; Parr and Parr, 1997), and an important question was
whether this is influenced by the route of priming. We found
that priming via the footpad or i.n. had little effect on the
magnitude of the HSV-specific IgG response after intravaginal
challenge. This result is consistent with the similar IgG MBC
frequencies in the IliLN after footpad or i.n. infection, although
circulating MBCs entering the responding IliLN after challenge
may also have contributed to the magnitude of the secondary
response. Overall, the impression is that the characteristics of
MBC trafficking ensure optimal secondary IgG responses,
regardless of the route of priming.
Interestingly, the secondary response to intravaginal chal-
lenge included little IgA production, even after i.n. priming.
Although we did not determine IgA MBC frequencies in this
study, it is likely that IgA MBCs would have been generated in
parallel with the IgA response to i.n. infection. The primary
HSV-specific response to intravaginal infection typically
includes only a small IgA component (Milligan and Bernstein,
1995), and it may be that local tissue factors direct the isotype
expression profile of not only the primary response (Sangster et
al., 1997), but also that of the memory response. Alternatively,
IgA MBCs may distribute differently from IgG MBCs (Moser
and Offit, 2001) and may not localize in the IliLN. This
important issue has not been resolved.
When the cellularity of the tissues sampled in our study is
considered, the spleen contained the vast majority of HSV-
specific MBCs, regardless of the route of infection. The count
per spleen of approximately 4000–5000 is similar to the
number of specific MBCs in this location determined by others
following infection with influenza (Li et al., 2006) and LCMV(Slifka et al., 1998). Taken together, these findings suggest a
strong similarity in the total number of specific MBCs
generated by diverse viruses with different primary sites of
replication. Perhaps notably, all of the viral infections studied
elicit strong primary B cell responses, and this may be the
critical determinant of the size of the MBC pool and the level
of protection conferred. It will be of interest to relate the MBC
frequencies generated by viral infections to those resulting
from various vaccination strategies.
Materials and methods
Mice
C57BL/6 mice were purchased from Harlan Sprague-
Dawley (Indianapolis, IN). Mice were housed under specific
pathogen-free conditions until infection, and thereafter in BSL2
containment. Female mice were used in all studies and were first
infected at 8–10 weeks of age. The Animal Care and Use
Committee of the University of Tennessee approved all animal
procedures.
Viruses
Stocks of the KOS and McKrae strains of HSV were grown
and titrated in Vero cells (ATCC CCL81) and stored in aliquots
at −80 °C. HSV KOS was concentrated from tissue culture
grown virus by centrifugation and inactivated by treatment with
β-propiolactone (BPL) (Li et al., 2006).
Infection and sampling
HSV KOS was used for footpad and intranasal infection, and
HSV McKrae was used for intravaginal infection. Mice were
anesthetized intraperitoneally with Avertin (2,2,2-tribromoetha-
nol) prior to receiving 5×105 PFU of HSV i.n. (in 30 μl PBS),
or 5×105 PFU of HSV (in 20 μl PBS) in each hind footpad. The
intravaginal HSV dose was 1×106 PFU (in 20 μl PBS) given
5 days after subcutaneous injection (100 μl) of 2 mg/ml Depo-
Provera (medroxyprogesterone acetate; Pharmacia and Upjohn,
Kalamazoo, MI).
Anesthetized mice were exsanguinated via the retro-orbital
plexus before tissue sampling. Tissues were processed to
generate single-cell suspensions in IMDM (Invitrogen, Carls-
bad, CA) containing L-glutamine (2 mM), sodium pyruvate
(1 mM), penicillin (100 IU/ml), streptomycin (100 μg/ml),
gentamicin (10 μg/ml), and 5×10−5 M β-mercaptoethanol
(designated B cell medium, BCM), and supplemented with 10%
fetal bovine serum (FBS). Lymph nodes [CLN, MLN, inguinal
(IngLN), IliLN, and PLN] and spleen were collected and gently
disrupted between the frosted ends of microscope slides. BM
cell suspensions were obtained by flushing the femurs and
tibiae. Red blood cells were removed from the spleen and BM
preparations by ammonium chloride lysis. NALT was collected
attached to the palate (Asanuma et al., 1997) and cells were
released by teasing. PP were dissected from the small intestine
and washed, and cells were released by digestion with 2 mg/ml
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37 °C. Washings from the vaginal tract were collected by
flushing several times with 200 μl PBS. Sera and vaginal
washings were stored at −80 °C.
ELISPOT assay
The ELISPOT assay was adapted to enumerate HSV-specific
ASCs (Li et al., 2006). Nitrocellulose-bottomed 96-well
Multiscreen HA filtration plates (Millipore, Bedford, MA)
were coated with purified, detergent-disrupted HSV and
blocked. Serial five-fold dilutions of single cell suspensions
were prepared in BCM containing 10% FBS, and 100 μl
volumes were added to the plates. Plates were incubated for 3–
4 h at 37 °C in a humidified atmosphere containing 5% CO2
and then washed thoroughly. Alkaline phosphatase (ALP)-
conjugated isotype-specific goat anti-mouse Abs (Southern
Biotechnology, Birmingham, AL) diluted 1:500 in PBS plus
5% BSA were added, and the plates were incubated overnight
at 4 °C. After extensive washing, spots were developed at
room temperature with 1 mg/ml of 5-bromo-4-chloro-3-indolyl
phosphate (Sigma, St. Louis, MO) in diethanolamine buffer.
Plates were washed and dried after optimal spot development,
and spots representing individual ASCs were counted using an
Olympus SZX9 stereozoom microscope. The specificity of the
assay was established by coating control plates with purified A/
HKx31 (H3N2) influenza A virus.
Memory B cell assay
An LDA for determining HSV-specific MBC frequencies was
used as described in detail previously. Briefly, two-fold dilutions of
cells from immune mice were incubated in 96-well tissue culture
plates, together with 106 irradiated (3000 rad) syngeneic naïve
spleen cell feeders plus BPL-inactivated HSV particles (0.01 μg/
well). Plates were incubated for 4 days at 37 °C in a humidified
atmosphere containing 5% CO2. During this time, HSV-specific
MBCs are stimulated to divide and differentiate into ASCs. After
incubation, cells in each well were washed thoroughly and
transferred to plates for the enumeration of HSV-specific ASCs by
ELISPOT assay (described above). The ELISPOT plates were
developed with ALP-conjugated goat anti-mouse IgG (Southern
Biotechnology) to identify IgG ASCs. Pre-existing virus-specific
ASC numbers in immune cell populations at the time of sampling
were determined by direct ex vivo ELISPOT assay. After in vitro
MBC activation and ELISPOT analysis, individual wells were
scored positive for virus-specific MBCs if progeny ASC numbers
were greater than the mean pre-existing ASC number plus
3 standard deviations. A minimum of 6 progeny ASCs were also
required for a well to be scored positive. The virus-specific IgG
MBC frequency was calculated from the number of negative wells
per cell dilution by extrapolation to the dilution that gave 37%
negative wells (Topham and Doherty, 1998). Virus-specific IgG
MBCs are defined as cells that, upon in vitro stimulation, give rise
to IgGASCs (Coffman and Cohn, 1977; Okumura et al., 1976). At
the time of sampling, immune cell populations were characterized
by flow cytometry using FITC-conjugated anti-CD3ε (145-2C11)and PE-conjugated anti-B220 (RA3-6B2) mAbs (BDBiosciences)
as staining reagents. To accommodate lymphoid tissue differences
in the proportion of B220+ B cells, the population that includes the
MBCs (Bell and Gray, 2003; Blink et al., 2005; Li et al., 2006),
MBC frequencies are expressed for B220+ cells.
ELISA
Levels of HSV-specific Abs in serum and the vaginal wash
were determined by ELISA using Costar immunoassay plates
(Corning, Acton, MA) coated with purified, detergent-
disrupted HSV (0.5 μg/well). Serial three-fold serum dilutions
starting at 1:100, or a 1:20 dilution of the vaginal wash, were
added to the plates. Otherwise, the ELISA was completed as
described previously (Sangster et al., 2000) using ALP-
conjugated goat anti-mouse IgG or IgA Abs (Southern
Biotechnology) and p-nitrophenyl phosphate for detection of
bound Abs. Absorbance at 405 nm was read using a
SpectraMax 340 microplate reader (Molecular Devices,
Sunnyvale, CA). Ab concentrations in arbitrary units per
milliliter were calculated from standard curves constructed
using goat anti-mouse IgG or IgA capture Abs and purified
mouse Ig standards (Southern Biotechnology).
Statistics
Statistical comparisons of mean values were performed
using a two-tailed nonparametric Mann–Whitney U test for
unpaired samples.
Acknowledgments
This work was supported by National Institutes of Health
Grants AI106336501 (to B.T.R.) and AI061709 (to M.Y.S.).
References
Asanuma, H., Thompson, A.H., Iwasaki, T., Sato, Y., Inaba, Y., Aizawa, C.,
Kurata, T., Tamura, S., 1997. Isolation and characterization of mouse nasal-
associated lymphoid tissue. J. Immunol. Methods 202, 123–131.
Bachmann, M.F., Kundig, T.M., Odermatt, B., Hengartner, H., Zinkernagel,
R.M., 1994. Free recirculation of memory B cells versus antigen-dependent
differentiation to antibody-forming cells. J. Immunol. 153, 3386–3397.
Baine, Y., Thorbecke, G.J., 1982. Induction and persistence of local B cell
memory in mice. J. Immunol. 128, 639–643.
Bell, J., Gray, D., 2003. Antigen-capturing cells can masquerade as memory B
cells. J. Exp. Med. 197, 1233–1244.
Bernasconi, N.L., Traggiai, E., Lanzavecchia, A., 2002. Maintenance of
serological memory by polyclonal activation of human memory B cells.
Science 298, 2199–2202.
Biswas, P.S., Rouse, B.T., 2005. Early events in HSV keratitis—Setting the
stage for a blinding disease. Microbes Infect. 7, 799–810.
Blink, E.J., Light, A., Kallies, A., Nutt, S.L., Hodgkin, P.D., Tarlinton, D.M.,
2005. Early appearance of germinal center-derived memory B cells and
plasma cells in blood after primary immunization. J. Exp. Med. 201,
545–554.
Coffman, R.L., Cohn, M., 1997. The class of surface immunoglobulin on virgin
and memory B lymphocytes. J. Immunol. 118, 1806–1815.
Crotty, S., Felgner, P., Davies, H., Glidewell, J., Villarreal, L., Ahmed, R., 2003.
Cutting edge: long-term B cell memory in humans after smallpox
vaccination. J. Immunol. 171, 4969–4973.
142 D.J. Vanitha et al. / Virology 360 (2007) 136–142Hyland, L., Sangster, M., Sealy, R., Coleclough, C., 1994. Respiratory virus
infection of mice provokes a permanent humoral immune response. J. Virol.
68, 6083–6086.
Jones, P.D., Ada, G.L., 1987. Persistence of influenza virus-specific antibody-
secreting cells and B-cell memory after primary murine influenza virus
infection. Cell. Immunol. 109, 53–64.
Jones, C.M., Cose, S.C., Coles, R.M., Winterhalter, A.C., Brooks, A.G.,
Heath, W.R., Carbone, F.R., 2000. Herpes simplex virus type 1-specific
cytotoxic T-lymphocyte arming occurs within lymph nodes draining the
site of cutaneous infection. J. Virol. 74, 2414–2419.
Khanna, K.M., Lepisto, A.J., Decman, V., Hendricks, R.L., 2004. Immune
control of herpes simplex virus during latency. Curr. Opin. Immunol. 16,
463–469.
Kim, C.H., 2004. Chemokine–chemokine receptor network in immune cell
trafficking. Curr. Drug Targets Immune. Endocr. Metabol. Disord. 4,
343–361.
King, N.J., Parr, E.L., Parr, M.B., 1998. Migration of lymphoid cells from
vaginal epithelium to iliac lymph nodes in relation to vaginal infection by
herpes simplex virus type 2. J. Immunol. 160, 1173–1180.
Li, X., Vanitha, D.J., Joo, H.M., He, Y., Rouse, B.T., Sangster, M.Y., 2006. A
strategy for selective, CD4+ T cell-independent activation of virus-specific
memory B cells for limiting dilution analysis. J. Immunol. Methods 313,
110–118.
Liang, B., Hyland, L., Hou, S., 2001. Nasal-associated lymphoid tissue is a site
of long-term virus-specific antibody production following respiratory virus
infection of mice. J. Virol. 75, 5416–5420.
McHeyzer-Williams, L.J., McHeyzer-Williams, M.G., 2005. Antigen-specific
memory B cell development. Annu. Rev. Immunol. 23, 487–513.
Milligan, G.N., Bernstein, D.I., 1995. Generation of humoral immune responses
against herpes simplex virus type 2 in the murine female genital tract.
Virology 206, 234–241.
Morrison, L.A., Zhu, L., Thebeau, L.G., 2001. Vaccine-induced serum
immunoglobin contributes to protection from herpes simplex virus type 2
genital infection in the presence of immune T cells. J. Virol. 75, 1195–1204.
Moser, C.A., Offit, P.A., 2001. Distribution of rotavirus-specific memory B cells
in gut-associated lymphoid tissue after primary immunization. J. Gen. Virol.
82, 2271–2274.
Okumura, K., Julius, M.H., Tsu, T., Herzenberg, L.A., Herzenberg, L.A., 1976.
Demonstration that IgG memory is carried by IgG-bearing cells. Eur. J.
Immunol. 6, 467–472.
Parr, E.L., Parr, M.B., 1997. Immunoglobulin G is the main protective antibody
in mouse vaginal secretions after vaginal immunization with attenuated
herpes simplex virus type 2. J. Virol. 71, 8109–8115.Pereira, R.A., Scalzo, A., Simmons, A., 2001. Cutting edge: a NK complex-
linked locus governs acute versus latent herpes simplex virus infection of
neurons. J. Immunol. 166, 5869–5873.
Reading, P.C., Whitney, P.G., Barr, D.P., Smyth, M.J., Brooks, A.G., 2006. NK
cells contribute to the early clearance of HSV-1 from the lung but cannot
control replication in the central nervous system following intranasal
infection. Eur. J. Immunol. 36, 897–905.
Roy, M.P., Kim, C.H., Butcher, E.C., 2002. Cytokine control of memory B cell
homing machinery. J. Immunol. 169, 1676–1682.
Sangster, M., Hyland, L., Sealy, R., Coleclough, C., 1995. Distinctive kinetics of
the antibody-forming cell response to Sendai virus infection of mice in
different anatomical compartments. Virology 207, 287–291.
Sangster, M.Y., Mo, X.Y., Sealy, R., Coleclough, C., 1997. Matching
antibody class with pathogen type and portal of entry: cognate
mechanisms regulate local isotype expression patterns in lymph nodes
draining the respiratory tract of mice inoculated with respiratory
viruses, according to virus replication competence and site of inoculation.
J. Immunol. 159, 1893–1902.
Sangster, M.Y., Topham, D.J., D'Costa, S., Cardin, R.D., Marion, T.N., Myers,
L.K., Doherty, P.C., 2000. Analysis of the virus-specific and nonspecific B
cell response to a persistent B-lymphotropic gammaherpesvirus. J. Immunol.
164, 1820–1828.
Sangster, M.Y., Riberdy, J.M., Gonzalez, M., Topham, D.J., Baumgarth, N.,
Doherty, P.C., 2003. An early CD4+ T cell-dependent immunoglobulin A
response to influenza infection in the absence of key cognate T–B
interactions. J. Exp. Med. 198, 1011–1021.
Schittek, B., Rajewsky, K., 1990. Maintenance of B-cell memory by long-lived
cells generated from proliferating precursors. Nature 346, 749–751.
Simmons, A., Bowden, R., Slobedman, B., 1997. Retention of herpes simplex
virus DNA sequences in the nuclei of mouse footpad keratinocytes after
recovery from primary infection. J. Gen. Virol. 78, 867–871.
Slifka, M.K., Ahmed, R., 1996. Limiting dilution analysis of virus-specific
memory B cells by an ELISPOT assay. J. Immunol. Methods 199, 37–46.
Slifka, M.K., Matloubian, M., Ahmed, R., 1995. Bone marrow is a major site of
long-term antibody production after acute viral infection. J. Virol. 69,
1895–1902.
Slifka, M.K., Antia, R., Whitmire, J.K., Ahmed, R., 1998. Humoral immunity
due to long-lived plasma cells. Immunity 8, 363–372.
Topham, D.J., Doherty, P.C., 1998. Longitudinal analysis of the acute Sendai virus-
specific CD4+ T cell response and memory. J. Immunol. 161, 4530–4535.
Zammit, D.J., Turner, D.L., Klonowski, K.D., Lefrancois, L., Cauley, L.S.,
2006. Residual antigen presentation after influenza virus infection affects
CD8 T cell activation and migration. Immunity 24, 439–449.
